Dapagliflozin And Metformin Hydrochloride Tablet, Film Coated, Extended Release
Product Images NDC 66993-362

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Dapagliflozin And Metformin Hydrochloride (NDC 66993-362). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Prasco Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 4 (Figure 4)

FDA Label Image

Figure 5 (Figure 5)

FDA Label Image

Figure-6 (Figure 6)

FDA Label Image

Figure-7 (Figure 7)

Figure-7 (Figure 7)
Dapagliflozin vs. Placebo: This description provides information about a comparison between Dapagliflozin and Placebo. It includes data points for different months from randomization and patients at risk for both groups. The hazard ratio (HR) with a 95% confidence interval is also provided.*
FDA Label Image

Dapagliflozin Chemical Structure (Image 01)

FDA Label Image

Metformin Hydrochloride Chemical Structure (Image 02)

FDA Label Image

Figure 1 (Image 03)

FDA Label Image

Figure 2 (Image 04)

FDA Label Image

Figure 3: Graph (Image 05)

FDA Label Image

5mg_1000mg (Image 08)

FDA Label Image

10mg_1000mg (Image 10)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.